Regulatory Investigation

RNS Number : 6698N

Accrol Group Holdings PLC

21 January 2019

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.  Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

21 January 2019

Accrol Group Holdings plc

("Accrol" or the "Company")

AIM: ACRL

Regulatory Investigation

The Financial Conduct Authority (the "FCA") has notified Accrol that it has commenced an investigation into the Company relating to certain statements that it made to the market between 1 April 2017 and 20 November 2017.  Accrol is cooperating fully with the FCA.

The Company will issue its Half Year Results for the six months ended 31 October 2019 tomorrow, as previously announced.

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman	Tel: [phone]
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser & Broker)
Dan Bate / Andrew Jones	Tel: [phone]
Dominic King / John Goold	Tel: [phone]
Belvedere Communications Limited
Cat Valentine ([e-mail])	Tel: [phone]
Keeley Clarke ([e-mail])	Tel: [phone]

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 

Accrol operates from three sites:

·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.

 

END

 

 

MSCCKDDDQBKDNDB